Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bas ten Harkel

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Plos One|October 2, 2015
The Foreign Body Giant Cell Cannot Resorb Bone, But Dissolves Hydroxyapatite Like OsteoclastsBas ten Harkel, Ton Schoenmaker, Daisy I Picavet, et al.
Biomaterials|June 15, 2014
Osteoclast resorption of beta-tricalcium phosphate controlled by surface architectureNoel L Davison, Bas ten Harkel, Ton Schoenmaker, et al.
Journal of Structural Biology|May 8, 2016
Ultrastructural aspects of foreign body giant cells generated on different substratesBas Ten Harkel, Jelle Koopsen, Sander M van Putten, et al.
Journal of Leukocyte Biology|December 7, 2016
Genetic modification of ER-Hoxb8 osteoclast precursors using CRISPR/Cas9 as a novel way to allow studies on osteoclast biologyIrene Di Ceglie, Guus G H van den Akker, Giuliana Ascone, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Plos One|October 2, 2015
The Foreign Body Giant Cell Cannot Resorb Bone, But Dissolves Hydroxyapatite Like OsteoclastsBas ten Harkel, Ton Schoenmaker, Daisy I Picavet, et al.
Biomaterials|June 15, 2014
Osteoclast resorption of beta-tricalcium phosphate controlled by surface architectureNoel L Davison, Bas ten Harkel, Ton Schoenmaker, et al.
Journal of Structural Biology|May 8, 2016
Ultrastructural aspects of foreign body giant cells generated on different substratesBas Ten Harkel, Jelle Koopsen, Sander M van Putten, et al.
Journal of Leukocyte Biology|December 7, 2016
Genetic modification of ER-Hoxb8 osteoclast precursors using CRISPR/Cas9 as a novel way to allow studies on osteoclast biologyIrene Di Ceglie, Guus G H van den Akker, Giuliana Ascone, et al.
Pageof 1